Abstract
Persistence of IDH1 or IDH2 mutations in remission bone marrow specimens of patients with acute myeloid leukemia has been observed, but the clinical impact of these mutations is not well known. In this study, we evaluated 80 acute myeloid leukemia patients with known IDH1 R132 or IDH2 R140/R172 mutations and assessed their bone marrow at the time of remission to determine the potential impact of persistent IDH1/2 mutations. Approximately 40% of acute myeloid leukemia patients given standard treatment in this cohort had persistent mutations in IDH1/2 Patients with an IDH1/2 mutation had an increased risk of relapse after 1 year of follow-up compared to patients without a detectable IDH1/2 mutation (59% versus 24%; P<0.01). However, a persistent mutation was not associated with a shorter time to relapse. High IDH1/2 mutation burden (mutant allelic frequency ≥10%) did not correlate with relapse rate (77% versus 86% for patients with a low burden, i.e., mutant allelic frequency <10%; P=0.66). Persistent mutations were also observed in NPM1, DNMT3A and FLT3 during remission, but IDH1/2 mutations remained significant in predicting relapse by multivariate analysis. Flow cytometry was comparable and complementary to next-generation seq...Continue Reading
Citations
Jun 5, 2019·International Journal of Laboratory Hematology·Ziwei WangGusheng Tang
Dec 6, 2019·Cancer Medicine·Ali SakhdariChi Young Ok
Dec 6, 2019·British Journal of Haematology·Jack GhannamChristopher S Hourigan
Mar 20, 2020·Journal of Clinical Medicine·Cristina PanuzzoDaniela Cilloni
Apr 2, 2020·Blood·Robert P HasserjianBenjamin L Ebert
Jun 19, 2019·Cytometry. Part B, Clinical Cytometry·Zhining ChenSa A Wang
Jan 23, 2020·Journal of Clinical Medicine·Jessica PetitiDaniela Cilloni
Dec 7, 2019·Hematology·Sylvie D Freeman, Christopher S Hourigan
Oct 9, 2020·JAMA Oncology·Nicholas J ShortFarhad Ravandi
Aug 30, 2020·Cancers·Ugo TestaElvira Pelosi
Dec 30, 2020·Leukemia & Lymphoma·Diego CarbonellCarolina Martínez-Laperche
Feb 23, 2021·British Journal of Haematology·Sanam LoghaviSa A Wang
Mar 19, 2021·Neoplasia : an International Journal for Oncology Research·Yingjun WangKen H Young
Mar 25, 2021·The Journal of Experimental Medicine·Lucille StuaniJean-Emmanuel Sarry
Apr 10, 2021·Cold Spring Harbor Molecular Case Studies·Zoltán N OltvaiPawel Mroz
Jun 3, 2021·International Journal of Molecular Sciences·Deirdra VenneyKen I Mills
Jun 15, 2020·Leukemia Research·Scott C SmithJennifer N Sanmann
Jun 22, 2021·PloS One·Petra KövyHajnalka Andrikovics
Jul 17, 2021·International Journal of Laboratory Hematology·Jingtao LuHongying Chao
Aug 12, 2021·Leukemia·Luca Vincenzo CappelliAlexander Höllein
Aug 19, 2021·European Journal of Haematology·Amy SongMohammad O Hussaini
Jul 30, 2021·Cancer Research·Liat GoldbergPeter D Aplan
Dec 28, 2021·Frontiers of Medicine·Jingming LiKankan Wang